DK1373261T3 - Cyklopropaheterocykler som non-nukleotid revers transkriptase-hæmmer - Google Patents
Cyklopropaheterocykler som non-nukleotid revers transkriptase-hæmmerInfo
- Publication number
- DK1373261T3 DK1373261T3 DK02748329.6T DK02748329T DK1373261T3 DK 1373261 T3 DK1373261 T3 DK 1373261T3 DK 02748329 T DK02748329 T DK 02748329T DK 1373261 T3 DK1373261 T3 DK 1373261T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclopropaheterocycles
- reverse transcriptase
- transcriptase inhibitor
- nucleotide reverse
- nucleotide
- Prior art date
Links
- 229940123527 Nucleotide reverse transcriptase inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
- C07C245/14—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
- C07C245/18—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0100733A SE0100733D0 (sv) | 2001-03-05 | 2001-03-05 | Non-nucleoside reverse transcriptase inhibitors |
| PCT/EP2002/002328 WO2002070516A2 (en) | 2001-03-05 | 2002-03-04 | Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1373261T3 true DK1373261T3 (da) | 2011-08-29 |
Family
ID=20283208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02748329.6T DK1373261T3 (da) | 2001-03-05 | 2002-03-04 | Cyklopropaheterocykler som non-nukleotid revers transkriptase-hæmmer |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6716850B2 (da) |
| EP (1) | EP1373261B1 (da) |
| JP (2) | JP4463478B2 (da) |
| KR (1) | KR100884494B1 (da) |
| CN (2) | CN1264839C (da) |
| AR (1) | AR035941A1 (da) |
| AT (1) | ATE508128T1 (da) |
| AU (1) | AU2002308231B2 (da) |
| BR (1) | BR0207886A (da) |
| CA (1) | CA2438524C (da) |
| DE (1) | DE60239924D1 (da) |
| DK (1) | DK1373261T3 (da) |
| ES (1) | ES2364926T3 (da) |
| IL (2) | IL157543A0 (da) |
| MX (1) | MXPA03008040A (da) |
| MY (1) | MY137083A (da) |
| PL (1) | PL207392B1 (da) |
| RU (1) | RU2281284C2 (da) |
| SE (1) | SE0100733D0 (da) |
| TW (1) | TWI228990B (da) |
| WO (1) | WO2002070516A2 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1534276B1 (en) * | 2002-09-05 | 2008-11-05 | Medivir AB | Non-nucleoside reverse transcriptase inhibitors |
| US20050130974A1 (en) * | 2003-10-17 | 2005-06-16 | Rigel Pharmaceuticals, Inc. | Benzothiazole compositions and their use as ubiquitin ligase inhibitors |
| SE0400021D0 (sv) * | 2004-01-08 | 2004-01-08 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| JP4762917B2 (ja) * | 2004-01-08 | 2011-08-31 | メディヴィル・アクチボラグ | 非ヌクレオシド逆転写酵素インヒビター |
| GB0608876D0 (en) | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
| ATE552245T1 (de) | 2006-05-15 | 2012-04-15 | Merck Sharp & Dohme | Antidiabetische bicyclische verbindungen |
| US9670203B2 (en) * | 2013-06-28 | 2017-06-06 | Beigene, Ltd. | Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors |
| US9670231B2 (en) | 2013-06-28 | 2017-06-06 | Beigene, Ltd. | Fused tricyclic amide compounds as multiple kinase inhibitors |
| WO2015089842A1 (en) * | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Novel tricyclic calcium sensing receptor antagonists for the treatment of osteoporosis |
| TWI909513B (zh) | 2019-01-25 | 2025-12-21 | 英屬開曼群島商百濟神州有限公司 | 作為b-raf激酶二聚體抑制劑之化合物及其製備方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA973885A (en) * | 1969-08-22 | 1975-09-02 | Universal Oil Products Company | Vinylation of aromatic compounds |
| US3803175A (en) | 1969-08-22 | 1974-04-09 | Universal Oil Prod Co | Preparation of coumarin compounds |
| US4931221A (en) * | 1988-12-30 | 1990-06-05 | Ppg Industries, Inc. | Photochromic spiropyran compounds |
| IL102548A (en) | 1991-08-02 | 1998-08-16 | Medivir Ab | Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds |
| CA2115427C (en) * | 1991-08-14 | 2000-05-02 | Stanford Salvatore Pelosi Jr. | Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| CZ286265B6 (cs) * | 1991-08-14 | 2000-03-15 | Procter And Gamble Pharmaceuticals | Cyklické sloučeniny močoviny a farmaceutický prostředek, který je obsahuje |
| CA2168447C (en) * | 1993-08-24 | 2006-07-11 | Peter Thomas Lind | Compounds and methods for inhibition of hiv and related viruses |
| BR9906933A (pt) * | 1998-01-16 | 2001-11-27 | Medivir Ab | Antiviróticos |
| US5998411A (en) | 1998-03-17 | 1999-12-07 | Hughes Institute | Heterocyclic nonnucleoside inhibitors of reverse transcriptase |
| WO1999051613A1 (en) | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| US6136335A (en) | 1998-12-31 | 2000-10-24 | Hughes Institute | Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| US7186736B1 (en) | 1999-03-20 | 2007-03-06 | Parker Hughes Institute | NNI for treatment of multi-drug resistant HIV |
| US6207688B1 (en) | 1999-06-23 | 2001-03-27 | Parker Hughes Institute | Phenethyl-thiourea compounds and use |
| US6469034B1 (en) | 1999-06-23 | 2002-10-22 | Parker Hughes Institute | Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase |
| US6124324A (en) | 1999-06-23 | 2000-09-26 | Hughes Institute | Thiophene-ethyl thiourea compounds and use |
-
2001
- 2001-03-05 SE SE0100733A patent/SE0100733D0/xx unknown
-
2002
- 2002-02-25 TW TW091103297A patent/TWI228990B/zh not_active IP Right Cessation
- 2002-03-01 MY MYPI20020739A patent/MY137083A/en unknown
- 2002-03-04 PL PL364414A patent/PL207392B1/pl not_active IP Right Cessation
- 2002-03-04 CN CNB02806027XA patent/CN1264839C/zh not_active Expired - Fee Related
- 2002-03-04 CA CA2438524A patent/CA2438524C/en not_active Expired - Fee Related
- 2002-03-04 AU AU2002308231A patent/AU2002308231B2/en not_active Ceased
- 2002-03-04 MX MXPA03008040A patent/MXPA03008040A/es active IP Right Grant
- 2002-03-04 DK DK02748329.6T patent/DK1373261T3/da active
- 2002-03-04 IL IL15754302A patent/IL157543A0/xx unknown
- 2002-03-04 EP EP02748329A patent/EP1373261B1/en not_active Expired - Lifetime
- 2002-03-04 KR KR1020037011616A patent/KR100884494B1/ko not_active Expired - Fee Related
- 2002-03-04 RU RU2003129513/04A patent/RU2281284C2/ru not_active IP Right Cessation
- 2002-03-04 JP JP2002569836A patent/JP4463478B2/ja not_active Expired - Fee Related
- 2002-03-04 CN CN200610082490XA patent/CN101081843B/zh not_active Expired - Fee Related
- 2002-03-04 ES ES02748329T patent/ES2364926T3/es not_active Expired - Lifetime
- 2002-03-04 WO PCT/EP2002/002328 patent/WO2002070516A2/en not_active Ceased
- 2002-03-04 BR BR0207886-4A patent/BR0207886A/pt not_active IP Right Cessation
- 2002-03-04 AT AT02748329T patent/ATE508128T1/de not_active IP Right Cessation
- 2002-03-04 DE DE60239924T patent/DE60239924D1/de not_active Expired - Lifetime
- 2002-03-05 AR ARP020100797A patent/AR035941A1/es unknown
- 2002-03-05 US US10/092,752 patent/US6716850B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 US US10/377,057 patent/US6894177B2/en not_active Expired - Fee Related
- 2003-08-21 IL IL157543A patent/IL157543A/en not_active IP Right Cessation
-
2005
- 2005-03-02 US US11/071,675 patent/US7405310B2/en not_active Expired - Fee Related
-
2009
- 2009-02-10 JP JP2009028717A patent/JP2009102436A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033857D0 (no) | Benzofenoner som inhibitorer av revers transkriptase | |
| NO20021042D0 (no) | Benzofenoner som inhibitorer av revers transkriptase | |
| NO20033593D0 (no) | Kinazoliner som MMP-13 inhibitorer | |
| NO20043004L (no) | 4-oksokinolin forbindelse og anvendelse derav som HIV-integraseinhibitor | |
| PL375698A1 (pl) | Urządzenie medyczne posiadające inhibitor hydratacji | |
| NO20024997D0 (no) | 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer | |
| NO20033618L (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
| NO20052921D0 (no) | Fenylsubstituerte piperidinforbindelser for anvendelse som PPAR aktivatorer | |
| NO20043424L (no) | Tricykliske 2-pyrimidon forbindelser nyttige som HIV revers transkriptase inhibitorer | |
| DK1373261T3 (da) | Cyklopropaheterocykler som non-nukleotid revers transkriptase-hæmmer | |
| NO20044104L (no) | Ikke-nukleoside reverstranskriptase-inhibitorer | |
| NO20040133L (no) | Additiv og anvendelse derav som korrosjonsinhibitor | |
| DE50213815D1 (de) | Gewindeschneidwerkzeug | |
| DK1294720T3 (da) | Non-nukleosid revers transkriptase-inhibitorer | |
| DE60323572D1 (de) | Expansionsventil | |
| DE60327491D1 (de) | Entspannungsventil | |
| NO20033700D0 (no) | Isoksazolinderivater som anti-depressive midler | |
| DK1499622T3 (da) | Meterotricyclyl-6-alkylidenpenemer som beta-lactamaseinhibitorer | |
| DE60317999D1 (de) | Entspannungsventil | |
| DE60333884D1 (de) | Entspannungsventil | |
| NO20030248D0 (no) | Tricykliske pyridonforbindelser anvendelige som HIV revers- transkriptase-inhibitorer | |
| DE60324506D1 (de) | Expansionsventil | |
| NO20044043L (no) | Dipyridodiazepioner som revers-transkriptase-inhibitorer | |
| DK1373267T3 (da) | Non-nucleoside revers transkriptase-inhibitorer | |
| FI20021543A0 (fi) | Puolijohdemodulaattori |